HSCA today applauded government and industry action to ensure that the U.S. Food and Drug Administration (FDA) will continue to have access to the resources necessary to approve of safe, effective and affordable generic medicines. The FDA will begin collecting generic drug user fees from industry today, October 1, 2012.
“Timely access to effective and affordable medications is critical for American hospitals and patients. HSCA applauds both government and industry for each doing their part to help protect uninterrupted patient access to important treatments,” said HSCA President Curtis Rooney. “Group purchasing organizations are engines of healthcare cost savings and the purchasing partners to America’s 5,000+ hospitals. GPOs are acutely aware of the important role of generic prescriptions drugs in helping to control healthcare spending.”
Earlier this year, Congress authorized two new user fee programs for the generic drug and biosimilar industries. When Congress and the President failed to reach a spending agreement that reflected the new user fee programs, Congress subsequently acted to pass the FDA User Fee Corrections Act, which allowed FDA collection of generic drug user fees to move forward as planned.
35
36
37
38
